Response may vary across age groups, though evidence for consistent age-related differences in onset of action is limited
| Last Updated: January 30th, 2024 Retatrutide is most commonly used for weight loss or diabetes
Your healthcare provider will assess your individual circumstances to determine whether GLP-1 therapy is appropriate
Identity and Contact Information of the Data Controller This privacy policy applies to all personal data processed by Sensilab d.o.o., with its registered office at Verovkova 55a, 1000 Ljubljana, Slovenia, , company registration number 2113732000, and Vision Healthcare Group, with its registered office at Grote Markt 41, 8500 Kortrijk, Belgium, company registration number BE 0685.849.188, acting as joint controllers under the GDPR (hereafter called 'Data Controller')
Only logged in customers who have purchased this product may leave a review.
Then tirzepatide arrived and raised the bar, adding a second receptor target and delivering results that made semaglutide look modest by comparison